Among the most consistent concerns the Radiant Results clinical team hears from patients on semaglutide, tirzepatide, and similar GLP-1 receptor agonists are two closely related problems: declining skin elasticity and accelerating muscle loss
Trulicity vs Retatrutide: What to Do When One Fails At a glance Drug class (Trulicity) / GLP-1 receptor agonist (dulaglutide), once-weekly subcutaneous injection Drug class (Retatrutide) / GIP plus GLP-1 plus glucagon receptor triple agonist, once-weekly subcutaneous injection (Phase 3, not yet FDA-approved) Best weight loss (Trulicity) / 3.0 kg mean at 52 weeks in AWARD-11 high-dose arm Best weight loss (Retatrutide) / 24.2% mean body weight reduction at 48 weeks in Phase 2 (N=338) Cardiovascular outcome data / Trulicity: REWIND (N=9,901, Lancet 2019) showed 12% MACE reduction
For the first time, weight loss at this scale comes in a form that fits in a pocket
You could try and beat the odds by disembarking from the GLP-1 express weight loss train
Retatrutide x 10 Vials is supplied strictly for laboratory and scientific research purposes only
In controlled research environments, this compound has been observed to engage GLP-1, GIP, and glucagon receptor systems, which are associated with energy regulation and hormonal signaling processes
